Can Somatic Symptom Disorder Improve? Recovery and Long-Term Outlook

Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy

Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens

Somatic symptom disorder (SSD) can improve substantially. Some people experience remission of the disorder, others continue to have physical symptoms while recovering daily functioning and reducing distress, and some need extended or renewed care. The long-term outlook depends on the full clinical picture: the course of bodily symptoms, the degree of symptom-related anxiety and behavioral disruption, coexisting health conditions, available treatment, and the quality of continuing medical follow-up. Research supports meaningful improvement, although no reliable percentage or timetable predicts recovery for one individual. A four-year study of DSM-5 SSD documented both persistence and remission, while a recent evidence synthesis of persistent physical symptoms00623-8) describes treatment approaches that can reduce burden and help restore participation in life.

Recovery is best understood across several dimensions. A person's pain, dizziness, gastrointestinal complaints, or fatigue may decrease; fear about what symptoms signify may become more manageable; repeated checking and urgent reassurance seeking may decline; sleep, relationships, work, school, and physical activity may improve. These changes can occur at different rates. A person can make important gains in quality of life even when some symptoms remain, and remission of SSD does not imply that every underlying physical condition has disappeared.

What Does Recovery From Somatic Symptom Disorder Mean?

Somatic symptom disorder is a clinical diagnosis involving one or more distressing or disruptive physical symptoms together with excessive symptom-related thoughts, feelings, or behaviors. Under the DSM-5-TR framework, a person may be persistently preoccupied with symptom severity, experience a high level of health-related anxiety, or devote excessive time and energy to symptoms or health concerns. The symptomatic state is persistent, typically for more than six months, although the particular physical symptom may vary.

The physical sensations themselves are real. SSD can occur when a diagnosed medical disease is present, and medical illness can coexist with distressing symptom-related responses. Neither the diagnosis nor improvement through psychological treatment establishes that symptoms were invented or produced exclusively by psychological causes. For a separate explanation of criteria and assessment, see Somatic Symptom Disorder: Symptoms, Diagnosis, and Treatment.

Clinical recovery has at least four relevant dimensions. Symptom improvement means reduced intensity, frequency, interference, or unpredictability of bodily complaints. Psychological improvement means fewer catastrophic interpretations, lower persistent health-related distress, and greater tolerance of uncertainty. Behavioral improvement involves less repetitive checking, unproductive reassurance seeking, and activity avoidance. Functional improvement means greater capacity to pursue valued routines, social relationships, responsibilities, and activities. Clinicians evaluate progress across these dimensions because no single score captures the entire condition.

Improvement, response, remission, and relapse

Treatment response means a meaningful improvement in agreed symptoms or functioning. Partial remission can describe a substantial reduction in SSD-related clinical features while some remain; full remission refers to the diagnostic picture no longer meeting the relevant criteria after appropriate assessment. A temporary quiet period in physical symptoms is not by itself proof of sustained remission. Likewise, a flare of pain or health anxiety after a period of progress is not automatically a complete relapse.

The terms are important because research studies use different definitions. Some measure symptom severity, others assess diagnostic status, and others track physical functioning or quality of life. These outcomes cannot be collapsed into one universal recovery rate. Progress is often better represented by a trajectory—how the person is doing across months—than by one good or bad day.

Can Somatic Symptom Disorder Go Away Completely?

Yes. SSD can remit, including after long periods of symptoms. Remission is documented in longitudinal research, and treatment studies show that symptom distress and functional impairment can improve. Complete resolution of every bodily sensation is not required for a person to stop meeting the psychiatric diagnostic criteria, particularly when symptom-related thoughts, anxiety, and behaviors have become proportionate and manageable.

At the same time, persistent symptoms are common in people seeking specialist treatment, and the available longitudinal evidence does not justify promising permanent disappearance of SSD for every patient. Recovery experiences vary partly because research populations differ: patients referred to psychosomatic clinics often have more severe or longstanding problems than community samples, and modern DSM-5-TR SSD is not identical to older research categories such as somatoform disorder or medically unexplained symptoms.

Improvement is not linear. A period of stable sleep, regular movement, and manageable health concerns may be followed by a temporary increase in symptoms during an infection, a demanding life event, or a new medical problem. The useful clinical question is whether the person can recognize changes, receive appropriate medical assessment, and return to an effective care plan.

What Do Long-Term Studies Actually Show?

Four-year follow-up of people assessed for DSM-5 SSD

One of the more directly relevant prospective studies followed patients seen at a psychosomatic outpatient clinic. Behm and colleagues (2021) assessed 360 people at baseline and reassessed 112 after four years. Among those 112 participants, 34 had SSD at both time points, 24 had SSD at baseline but no longer met criteria at follow-up, 19 developed SSD between assessments, and 35 had SSD at neither assessment. The corresponding percentages of the follow-up sample were 30.4%, 21.4%, 16.9%, and 31.3%.

These are distinct diagnostic pathways, not a probability forecast for a newly diagnosed individual. In particular, 21.4% represents 24 of all 112 followed participants; it should not be presented as the overall remission probability for every person with SSD. The sample was drawn from a specialist setting, the number reassessed was much smaller than the initial group, and baseline clinical characteristics influenced the results. At baseline, higher psychological burden related to bodily symptoms and greater general anxiety were associated with persistent SSD four years later. Association in a single cohort does not establish that either factor inevitably causes a poor outcome.

This study offers a practical conclusion: SSD can be persistent, but diagnostic status changes over time in both directions. Ongoing attention to symptom-related distress, health anxiety, and daily functioning is relevant when clinicians evaluate recovery.

Five-year trajectories in people with persistent somatic symptoms

A larger longitudinal literature examines persistent somatic symptoms (PSS) rather than strictly DSM-5 SSD. In the PROSPECTS five-year cohort, researchers analyzed 297 adults with at least three available measurements. They identified relatively stable courses of bodily symptom severity alongside different trajectories of physical and mental functioning. The findings illustrate that symptom severity and functioning can move differently: some people improve physically or psychologically without an equally dramatic change in the raw intensity of symptoms.

PROSPECTS should not be read as a direct estimate of DSM-5-TR SSD remission. Persistent somatic symptoms are a wider clinical population, including people who may not meet SSD's particular psychological and behavioral diagnostic requirements. Nevertheless, the cohort informs an essential aspect of prognosis: the restoration of participation, autonomy, and perceived health matters in its own right.

How to interpret improvement percentages

Different studies measure different outcomes, recruit different patients, apply different treatments, and observe patients for different durations. A randomized trial's percentage responding to therapy is not the same as an untreated natural-history remission rate. A meta-analysis combining older somatoform disorders, functional somatic syndromes, and DSM-5 SSD provides useful treatment evidence but cannot yield an exact SSD-specific lifetime prognosis.

Attrition is another limitation. People who complete a multi-year follow-up may differ systematically from those who cannot be contacted or choose not to participate. This uncertainty is part of interpreting long-term evidence, especially in relatively small specialist cohorts.

How Long Does SSD Recovery Take?

There is no established fixed recovery period. Some individuals report useful improvements in symptoms or function during a structured course of psychotherapy or after building a consistent medical follow-up relationship. Others require several months to develop sustainable changes in symptom monitoring, sleep, activity patterns, treatment of comorbid conditions, and confidence in medical decision-making. People with more entrenched disability or complex physical illnesses may benefit from longer-term collaborative care.

A 2019 meta-analysis of 15 randomized trials involving 1,671 participants found that cognitive behavioral therapy (CBT) improved bodily symptoms and several other outcomes, with some benefits maintained at follow-up. These trials predominantly involved older somatoform or medically unexplained symptom categories, so their time frames should not be converted into a precise timetable for every present-day SSD patient.

In clinical practice, treatment goals are commonly reviewed at agreed intervals. Early goals may concern establishing an accurate formulation, understanding urgent warning signs, and making daily routines more consistent. Later goals may concern sustaining work or school participation, reducing the burden of symptom-related checking, handling flares, and determining whether care intensity can safely decrease.

What Factors Are Associated With a Better or Worse Outlook?

SSD prognosis emerges from the interaction of multiple circumstances. Research identifies associations at the group level, while individual prediction remains limited. The 2024 Lancet review on persistent physical symptoms00623-8) describes biological, psychological, behavioral, and health-system contributions to symptom persistence and management.

Symptom burden and the duration of difficulties

Greater symptom severity, prolonged disability, and sustained interference with everyday life can complicate recovery. Longstanding patterns may require more time to change because sleep disruption, deconditioning, disrupted routines, and persistent monitoring have become intertwined with the illness experience. However, duration alone is not a reliable measure of what recovery is possible. People can improve after years of difficulties, particularly when treatment addresses relevant mechanisms and unmet medical needs.

Health anxiety, catastrophic interpretations, and attention

When physical sensations are repeatedly interpreted as evidence of an imminent catastrophe, distress can intensify and lead to further checking or avoidance. Attention may become closely focused on normal fluctuations in the body, making sensations more salient. These processes are plausible maintaining mechanisms supported by broader symptom and behavioral research; they are not a complete explanation for every physical symptom or proof that a particular patient's symptoms are psychogenic.

The four-year SSD cohort found that baseline general anxiety and psychological burden from bodily symptoms were associated with persistence. Clinicians may therefore assess these experiences as potential treatment targets while continuing to evaluate physical health appropriately.

Depression, trauma history, sleep, and other conditions

Coexisting depression or anxiety can increase distress and make rehabilitation harder, but neither is required for SSD. Sleep disorders, painful medical conditions, autonomic symptoms, medication adverse effects, and other sources of physiological burden may also influence functioning and symptom experience. A trauma history may be relevant to some individuals' care, although it is not a prerequisite for SSD and must not be assumed to be the origin of symptoms.

A coordinated treatment plan may address depression, insomnia, medication effects, diagnosed disease, and SSD-related distress in parallel. When the medical problem is independently treatable, its treatment remains essential.

Access to care, continuity, and the therapeutic relationship

Fragmented healthcare can prolong uncertainty. Multiple unrelated consultations may result in repeated explanations, inconsistent plans, and testing that is either excessive or insufficiently targeted. Conversely, a clinician who explains the diagnosis respectfully, reviews previous findings, identifies meaningful red flags, and offers planned follow-up can improve the basis for long-term care.

A 2023 scoping review of healthcare-related factors in persistent somatic symptoms found considerable gaps in how studies described usual care, referrals, and the treatment setting. Differences between settings should not be interpreted as proof that any particular clinic causes a higher remission rate. Continuity and communication are important clinical principles; research still needs better comparative evidence about which organizational models most improve long-term SSD outcomes.

Which Treatments Can Support Recovery?

The strongest practical approach is individualized, collaborative care addressing medical conditions, bodily symptom burden, psychological distress, and meaningful daily functioning. Treatment is tailored to the person's clinical needs and preferences rather than organized around an assumption that all symptoms share one psychological cause.

Cognitive behavioral therapy

CBT has an established evidence base for reducing persistent physical symptom burden and associated distress. In SSD-related care, it may help a person examine catastrophic interpretations, reduce repetitive checking and reassurance cycles, gradually return to meaningful activities, approach feared situations where appropriate, and build flexible responses to uncomfortable sensations. It also helps identify patterns of attention, stress, sleep, and behavior that maintain disability.

The 2019 randomized-trial meta-analysis reported benefits for somatic symptoms, anxiety, depressive symptoms, and physical functioning, although effects on social functioning and healthcare visits were less clear. More recently, a 2025 network meta-analysis of 74 studies involving 8,277 participants found improvements in bodily symptom severity with both CBT and acceptance- or mindfulness-based treatments compared with waiting-list controls. These broad-study samples include several types of bodily distress and functional syndromes, not exclusively individuals diagnosed with DSM-5-TR SSD.

CBT is not a test of whether symptoms are real and does not require the patient to deny a physical illness. Its goals are improved coping, functioning, and reduced clinical distress in the presence of real bodily experiences.

Acceptance- and mindfulness-based approaches

Acceptance-oriented therapies may help some patients respond more flexibly to uncertainty and persistent sensations. The therapeutic target is reducing the degree to which discomfort controls behavior or overwhelms participation in daily activities. Mindfulness practices need individual adaptation; some people find intense internal body attention unhelpful, especially early in treatment.

The 2025 network meta-analysis suggests that acceptance- and mindfulness-based treatments can reduce somatic symptom severity, with benefits partly maintained over time. Interpretation remains sensitive to differences in intervention design, diagnostic populations, comparison conditions, and study quality.

Internet-delivered cognitive behavioral therapy

Remote, structured CBT can expand access, especially where qualified therapists are scarce. A 2026 meta-analysis of randomized trials examined internet-based CBT for SSD and related functional disorders, reporting improvements in somatic symptoms and health anxiety, including follow-up benefits in some studies. The evidence spans different diagnostic groups, formats, support levels, and control conditions. Digital treatment quality and clinician involvement should be considered rather than assuming all apps or general-purpose chatbots provide equivalent clinical care.

Coordinated medical care and regular appointments

A stable primary care clinician or coordinated team can help align investigations, medications, referrals, and treatment goals. Planned visits can provide space to review new symptoms, monitor medical conditions, assess changes in function, and decide when additional examination is necessary. Follow-up should be responsive to clinical developments; fixed appointments are not a reason to postpone evaluation of urgent symptoms.

The value of continued medical assessment is emphasized in modern approaches to persistent physical symptoms00623-8). A diagnosis of SSD can coexist with heart disease, inflammatory disorders, endocrine disease, neurological illness, and many other conditions. Relevant treatment of those conditions proceeds on its own merits.

Medication and comorbid conditions

There is no single medication that reliably cures SSD. Medication can be useful for particular coexisting conditions, such as major depression or a clinically significant anxiety disorder, and for appropriately diagnosed pain, sleep, or other medical problems. Treatment should consider benefits, adverse effects, drug interactions, and the possibility that side effects themselves can increase bodily symptom burden.

The choice of medication and whether to continue or taper it are decisions for the prescribing clinician and patient. New symptoms after medication changes deserve appropriate review; patients should not stop prescribed treatment solely because an SSD diagnosis has been made.

Rehabilitation and restoring activity

Functional recovery may involve physical therapy, occupational therapy, rehabilitation counseling, graded return to individually tolerable activities, pacing, and adjustments at work or school. The approach depends on the underlying illness, type of functional limitation, and clinical examination. Rehabilitation for an SSD patient with chronic pain should reflect relevant medical and pain-specific guidance rather than impose a generic activity formula.

Meaningful recovery goals may include walking to the store, attending classes, preparing a meal, participating in family life, or resuming paid work. The measure of improvement is negotiated with the individual and takes account of realistic capacity, safety, and fluctuating symptoms.

What If Physical Symptoms Persist After Treatment?

Continuing to experience bodily symptoms after psychotherapy does not mean treatment has failed. Improvement can consist of lower distress, more predictable self-management, fewer disruptive health fears, and greater independence. Treatment may also be less effective than hoped for some patients; care should then be reviewed rather than indefinitely repeated without reassessing the formulation.

The first clinical step is to identify what has and has not changed. Has the nature of the pain shifted? Are there new neurological deficits, unexplained weight changes, fever, bleeding, or other warning signs? Has an existing medical disease changed? Is there a previously overlooked sleep disorder, medication effect, depression, or major practical barrier to recovery? These questions require a medical and psychological assessment appropriate to the person's presentation.

If the working diagnosis remains supported, a clinician may revise goals or offer a different treatment modality, coordinate referrals, address comorbidities, or build a longer maintenance plan. A treatment plateau is information for clinical decision-making rather than evidence of deception or unwillingness to recover.

Why Do Symptoms Sometimes Flare During Recovery?

Symptoms can fluctuate with infection, poor sleep, physical load, medication changes, stress, hormonal changes, and many other influences. Some fluctuations are related to a diagnosed condition; others remain incompletely explained. Symptoms can also become more intrusive when attention, worry, and avoidance reinforce one another. None of these possibilities is established by observing a flare alone.

A useful relapse-prevention plan distinguishes a familiar, previously evaluated symptom pattern from a significant change requiring a fresh clinical examination. It describes whom to contact, which coping strategies have previously helped, and how to preserve essential routines without ignoring risk.

Some people experience renewed health anxiety when exposed to alarming health information or after an illness in a family member. This may be addressed with psychological tools and supportive appointments while preserving an appropriate route for new health concerns.

How Is Progress Measured Over Time?

A credible prognosis requires looking beyond the intensity of a single physical symptom. Clinicians may track symptom burden, diagnostic criteria, health anxiety, avoidance, healthcare use, quality of life, mood, and functional participation. Measures such as the Somatic Symptom Scale–8 (SSS-8) or Patient Health Questionnaire–15 (PHQ-15) can quantify symptom burden, while the Somatic Symptom Disorder–B Criteria Scale (SSD-12) examines associated cognitive, emotional, and behavioral features. These tools support assessment; no questionnaire establishes diagnosis, recovery, or medical safety on its own.

Patient-defined outcomes are equally important. Two people with the same score may have very different capacities to work, care for children, travel, sleep, or socialize. A collaborative plan can identify several observable goals, review them over time, and consider whether gains are durable through ordinary fluctuations.

When treatment is ineffective, the clinical formulation should remain open to revision. New symptoms, evolving physical illness, and unexpected deterioration warrant renewed attention even after SSD has been diagnosed.

Can SSD Improve When a Diagnosed Medical Condition Is Also Present?

Yes. SSD may coexist with an independently diagnosed medical condition, and improvement in the excessive symptom-related thoughts, distress, or behaviors can occur while the medical disease continues to require treatment. Changes in the medical condition may also affect symptom burden and outlook.

A person with inflammatory arthritis, for example, might receive appropriate rheumatological care and simultaneously work on distressing health preoccupation or activity avoidance. The improvement of one component cannot be used to dismiss the other. The clinical aim is integrated, proportionate care. For the detailed diagnostic boundary, see Somatic Symptom Disorder With a Medical Condition: How Both Are Assessed.

This distinction also matters when interpreting older literature on medically unexplained symptoms. Modern SSD does not require the physical symptom to lack a medical explanation. The history and limitations of that terminology are addressed in Medically Unexplained Symptoms: Medical Evaluation and Care for Persistent Physical Symptoms.

SSD Recovery Versus Other Diagnostic Conditions

Somatic symptom disorder is differentiated from illness anxiety disorder by the prominence of distressing bodily symptoms and the particular symptom-related diagnostic picture. Illness anxiety disorder generally centers on preoccupation with having or acquiring serious disease in the presence of absent or mild somatic symptoms. Either diagnosis requires full clinical evaluation, and both can involve checking and reassurance seeking. See Somatic Symptom Disorder vs Illness Anxiety Disorder: Key Differences.

SSD also differs from obsessive-compulsive disorder, panic disorder, depression, post-traumatic stress disorder, functional neurological disorder, and psychological factors affecting other medical conditions. Anxiety-related bodily symptoms or a positive screening score are not sufficient grounds to classify an individual as having SSD. Medical diagnoses, including neurologic and autonomic disorders, may require separate investigation and treatment.

International classification adds another consideration: ICD-11 bodily distress disorder and DSM-5-TR SSD have overlapping areas of concern but their criteria and conceptual structure are not fully interchangeable. Prognosis data gathered under an ICD diagnosis should therefore be identified as such rather than automatically counted as DSM-5-TR SSD outcome evidence. The World Health Organization's ICD-11 clinical requirements and APA's DSM-5-TR chapter provide their respective reference frameworks.

Children and Adolescents: Recovery and Development

Children and teens with persistent physical symptoms need developmentally appropriate evaluation, family-centered communication, and attention to school participation. The child's report of pain, nausea, dizziness, or fatigue deserves serious medical consideration. Clinicians assess health conditions, mental health, developmental stage, family stressors, school environment, and the impact of symptoms on daily life.

The Canadian Paediatric Society's 2024 guidance emphasizes respectful explanations, coordinated treatment, functional goals, and appropriate follow-up for somatic symptom and related disorders. Parents can support recovery by listening to the child, maintaining a clear medical plan, collaborating with school personnel, and helping restore suitable routines without coercion. School accommodations or a gradual return may be appropriate depending on medical and psychological needs.

Adult prognosis rates should not be applied to children. Pediatric studies may use different diagnostic groupings and outcome definitions, and the course may be influenced by development, family relationships, educational support, and access to specialized care.

When Is a New Medical Evaluation Necessary?

A prior SSD diagnosis should never become an automatic explanation for all future symptoms. New, rapidly worsening, or distinctly different bodily problems require appropriate assessment. Emergency evaluation is important for warning signs such as sudden one-sided weakness or facial droop, new severe chest pain with concerning features, severe breathing difficulty, significant bleeding, sudden severe headache, or acute loss of consciousness. The appropriate response depends on the symptoms and local emergency guidance.

Less urgent but persistent changes may also need medical review, including unexplained weight loss, progressive neurological signs, fever, unusual swelling, new gastrointestinal bleeding, and changes in established chronic disease. Avoiding unnecessary repetition of tests is compatible with ordering indicated tests when the clinical picture changes.

A sound recovery plan specifies how patients and clinicians will reassess a change in symptoms. Ongoing care is a safeguard for both psychological progress and physical health.

Building a Long-Term Recovery and Follow-Up Plan

A useful plan starts with shared clinical understanding. The clinician and patient discuss what is known about existing medical conditions, which SSD criteria are present, how symptom-related distress and behavior affect life, what additional investigation is justified, and which results would change management.

The next phase identifies realistic targets. These may include reducing an exhausting cycle of internet symptom searches, sleeping more consistently, returning to a valued activity with appropriate medical guidance, participating in psychotherapy, or arranging coordinated medical appointments. Goals should be specific enough to evaluate but flexible enough to accommodate illness fluctuations.

Maintenance focuses on durability. A person may need periodic follow-up, an agreed action plan for symptom flares, and a clear pathway back to care if depression, anxiety, functional impairment, or medical symptoms worsen. Decisions about reducing appointments or completing therapy are made collaboratively and can be reconsidered.

Effective follow-up also makes room for disagreement. If a patient reports that a treatment explanation does not fit their symptoms, or that disability has increased despite compliance, a clinician should reassess the situation. Respectful revision of the plan is part of competent care.

What Does Recent Research Add, and What Remains Uncertain?

Recent studies strengthen the evidence that multiple psychological treatments can reduce bodily symptom burden. A 2025 network meta-analysis compared CBT with acceptance- and mindfulness-based approaches across heterogeneous bodily distress conditions and found improvement relative to waiting lists; long-term effects were only partly maintained. A 2026 internet-CBT meta-analysis supports digitally delivered structured interventions for SSD and related disorders, while leaving questions about optimal patient selection and longer-term comparative effectiveness.

A 2026 longitudinal analysis of symptom development during psychosomatic treatment investigated symptom-factor changes across a large multisite clinical sample. It informs how symptom patterns change during treatment, but it cannot by itself supply lifetime SSD remission probabilities or demonstrate that every symptom follows one mechanism.

Several evidence gaps remain. Long-term studies using explicit DSM-5-TR SSD criteria are fewer than studies of broad persistent physical symptom categories. Recovery definitions are inconsistent. Follow-up samples can be selected and incomplete. Research still lacks a validated model that accurately predicts an individual's course, an established optimal sequence of therapies for every SSD presentation, and definitive evidence that any one treatment permanently prevents recurrence.

The appropriate evidence-based conclusion is that meaningful recovery is possible and care can improve symptoms and functioning. The precise probability, pace, and durability of improvement depend on the individual clinical context and cannot be determined from a diagnosis label alone.

Frequently Asked Questions

Is somatic symptom disorder lifelong?

It can persist for years in some people, but it is not inevitably lifelong. Longitudinal studies document both persistence and remission. The prognosis of one individual depends on symptom burden, coexisting conditions, treatment access, functional status, and other circumstances; no validated test predicts a fixed lifetime course.

What percentage of people recover from SSD?

There is no single defensible recovery percentage for all people with DSM-5-TR SSD. In one four-year specialty-clinic study, 24 of 112 reassessed patients had SSD at baseline but not at follow-up, while 34 had SSD at both times. Those figures describe the observed participants and must not be generalized as a population-wide cure or persistence rate.

Can symptoms improve without psychological treatment?

Some people improve over time or with effective treatment of a coexisting medical condition, changes in circumstances, supportive follow-up, and self-management. However, the natural history varies, and untreated severe impairment may continue. Evidence-based care is appropriate when symptoms, health anxiety, or behavior interfere significantly with daily life.

Does CBT cure somatic symptom disorder?

CBT can reduce bodily symptom severity, distress, associated anxiety, and functional impairment for many people, but clinical trials do not establish a universal or permanent cure. Its benefits and limitations differ across patients and studies. A structured treatment plan can be valuable even when some physical symptoms remain.

Can SSD return after remission?

Yes. Symptom-related anxiety, checking, and functional problems can recur, particularly during illness or major life disruption. A new physical symptom must still receive appropriate evaluation. Relapse-prevention planning helps maintain earlier gains and identify when additional treatment may be useful.

Does recovery mean doctors can stop investigating physical symptoms?

No. Medical investigation is determined by symptoms, examination findings, existing diagnoses, changes over time, and relevant warning signs. SSD can coexist with medical disease; new or progressive symptoms deserve appropriate assessment.

How can someone tell whether treatment is working?

Consider several outcomes together: symptom distress, degree of preoccupation, health-related behavior, participation in daily activities, sleep, social and occupational functioning, and quality of life. Clinicians may use standardized scales, but none is a substitute for diagnostic judgment or meaningful personal goals.

Is SSD prognosis the same as the prognosis of chronic pain or fibromyalgia?

No. Chronic pain and fibromyalgia have their own diagnostic, medical, and rehabilitation frameworks. Some studies combine these conditions with SSD under broad persistent symptom categories; their pooled outcomes should not be presented as SSD-specific prognosis estimates.

Does recovery require identifying an original psychological cause?

No. SSD diagnosis and treatment do not require identifying a single psychological event or trauma that caused the symptoms. Effective care can focus on symptom distress, health-related patterns, physical illness, and daily functioning while acknowledging uncertainty about mechanisms.

What should family members do to help?

Family members can listen without dismissing symptoms, support agreed treatment and medical follow-up, encourage attainable activities, and avoid turning every conversation into urgent reassurance or medical speculation. The patient's autonomy and preferences guide the approach. Family participation is particularly relevant for children and adolescents.

Related Articles

Somatic Symptom Disorder: Symptoms, Diagnosis, and Treatment explains the condition, diagnostic criteria, clinical assessment, and treatment overview.

Somatic Symptom Disorder Treatment: CBT and Coordinated Medical Care examines specific intervention approaches and care coordination.

Medically Unexplained Symptoms: Medical Evaluation and Care for Persistent Physical Symptoms explains terminology, ongoing assessment, and care for persistent symptoms.

Somatic Symptom Disorder With a Medical Condition: How Both Are Assessed addresses how SSD can coexist with diagnosed disease.

Somatic Symptom Disorder vs Illness Anxiety Disorder: Key Differences compares two related but distinct diagnostic presentations.

References

American Psychiatric Association. (2022). Somatic symptom and related disorders. In Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). https://doi.org/10.1176/appi.books.9780890425787.x09_Somatic_Symptom_and_Related_Disorders

Barends, H., et al. (2025). Five-year trajectories of symptom severity, physical and mental functioning in patients with persistent somatic symptoms: The PROSPECTS cohort study. BMJ Open, 15, e083276. https://doi.org/10.1136/bmjopen-2023-083276

Behm, A. C., Hüsing, P., Löwe, B., & Toussaint, A. (2021). Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic. Comprehensive Psychiatry, 110, 152265. https://doi.org/10.1016/j.comppsych.2021.152265

Canadian Paediatric Society. (2024). Somatic symptom and related disorders: Guidance on assessment and management. https://cps.ca/en/documents/position/somatic-symptom-and-related-disorders

Kustra-Mulder, A., Löwe, B., & Weigel, A. (2023). Healthcare-related factors influencing symptom persistence, deterioration, or improvement in patients with persistent somatic symptoms: A scoping review of European studies. Journal of Psychosomatic Research, 174, 111485. https://doi.org/10.1016/j.jpsychores.2023.111485

Liu, J., et al. (2019). The efficacy of cognitive behavioural therapy in somatoform disorders and medically unexplained physical symptoms: A meta-analysis of randomized controlled trials. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.10.114

Liu, S., et al. (2026). Efficacy of internet-based cognitive behavioral therapy on somatic symptom disorder and common related functional disorders: A meta-analysis of randomized controlled trials. General Hospital Psychiatry, 99, 92–101. https://doi.org/10.1016/j.genhosppsych.2026.01.017

Löwe, B., et al. (2024). Persistent physical symptoms: Definition, genesis, and management. The Lancet. https://doi.org/10.1016/S0140-6736(24)00623-800623-8)

Maas genannt Bermpohl, F., & Martin, A. (2025). Efficacy of cognitive behavioral therapy and acceptance- and mindfulness-based treatments in adults with bodily distress: A network meta-analysis. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000544825

Petzke, T. M., et al. (2026). A longitudinal bifactor approach to modelling somatic symptom development in psychosomatic treatment. Journal of Psychosomatic Research, 204, 112577. https://doi.org/10.1016/j.jpsychores.2026.112577

World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. https://www.who.int/publications/i/item/9789240077263